Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders. (2013).
Alterations in the endocannabinoid system in the rat valproic acid model of autism. (2013).

Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders. (2011).

Author(s): E.S. Onaivi, R. Benno, T. Halpern, M. Mehanovic, N. Schanz, C. Sanders, X. Yan, H. Ishiguro, Q-R Liu, A.L. Berzal, M.P. Viveros and S.F. Ali William Paterson.

These experiments demonstrated the therapeutic potential of cannabinoids to help treat autism. View study